Publications

Access journal articles that our team has developed on evidence that supports deprescribing. 

Author(s): Farrell, B, Galley, E, Jeffs, L, Howell, P, McCarthy, L. (2022, September)
Title: “Kind of blurry”: Deciphering clues to prevent, investigate and manage prescribing cascades
Journal: PLOS ONE (2022).
Doi: https://doi.org/10.1371/journal.pone.0272418 

Author(s): McCarthy L, Farrell B, Howell P, Quast T. (2022, August). 
Title: Supporting deprescribing in long-term care: An approach using stakeholder engagement, behavioural science and implementation planning
Journal: Exploratory Research in Clinical and Social Pharmacy
Doi: https://doi.org/10.1016/j.rcsop.2022.100168

Author(s): Galley E, Farrell B, Conklin J, Howell P, McCarthy L, Raman-Wilms L. (2022, August). 
Title: Using Community Engagement to Initiate Conversations About Medication Management and Deprescribing in Primary Care
Journal: Journal of Community Engagement and Scholarship
Link: https://jces.ua.edu/articles/10.54656/jces.v15i1.447 

Author(s): Farrell B, Grant R, Dilliott D, Granikov V, Sen HE, Grad R, Vuong V, Smith S, Pluye P. (2022, July). 
Title: Lessons learned from using whiteboard videos and YouTube for deprescribing guidelines knowledge mobilization
Journal: International Journal of Pharmacy Practice
Link: https://doi.org/10.1093/ijpp/riac054 

Author(s): Farrell B. (2022, March).
Title: Part 1: Interactive case: rational deprescribing of benzodiazepine receptor agonists for insomnia.
Journal: Journal of the American College of Clinical Pharmacy.
Doi: https://doi.org/10.1002/jac5.1612 

Author(s): Farrell B, Dilliott D, Richardson L, Conklin J, McCarthy L, Raman-Wilms L. (2022, March).
Title: “Talking about your medications” – a workshop series aimed at helping older adults participate in conversations about their medications.
Journal: Canadian Pharmacists Journal, 155(2), 86-92.
Doi: https://doi.org/10.1177/17151635221076075

Author(s):McCarthy L, Deng Z, Thompson W, Korenvain C, Lega I, Farrell B, Lochnan H. (2021).
Title: Benefits and harms of deprescribing antihyperglycemics for adults with type 2 diabetes: a systematic review.
Journal: Canadian Journal of Diabetes.
PDF: https://www.canadianjournalofdiabetes.com/article/S1499-2671(22)00009-0/fulltext 

Author(s): Tremblay Z, Mumbere-Bamusemba D, Laurin D, Sirois C, Furrer D, Poisblaud L, Carmichael PH, Farrell B, Tourigny A, Giguere A, Kroger E, Vedel I, Morais J. (2021).
Title: Health impacts and characteristics of deprescribing interventions in older adults: protocol for a systematic review and meta-analysis.
Journal: JMIR, 10(12), e25200.
Doi: 10.2196/25200

Author(s): Mangin D, Lamarche L, Agarwal G, Banh HL, Dore Brown N, Cassels A, Colwill K, Dolovich L, Farrell B, Garrison S, Gillett J, Griffith LE, Holbrook A, Jurcic-Vrataric J, McCormack J, O’Reilly D, Raina P, Richardson J, Risdon C, Savelli M, Sherifali D, Siu H, Tarride JE, Trimble J, Ali A, Freeman K, Langevin J, Parascandalo J, Templeton JA, Dragos S, Borhan S, Thabane L. (2021).
Title: Team Approach to Polypharmacy Evaluation and Reduction: Study Protocol for a Randomized Controlled Trial. 
Journal: BioMedCentral Trials, 746
Doi: https://doi.org/10.1186/s13063-021-05685-9

Author(s): Galley E, Farrell B, Conklin J, Howell P, McCarthy L, Raman-Wilms L. (2021).
Title: Using community engagement to initiate conversations about deprescribing in primary care.
Journal: Journal of Community Engagement and Scholarship.
Link: https://jces.ua.edu/articles/10.54656/jces.v15i1.447 

Author(s): Deveaux E, Farrell B, French Merkley V. (2021).
Title: An environmental scan to assess needs of geriatric day hospital patients and plan service delivery during the Covid-19 pandemic.
Journal: CGS Journal of CME, 11(1), 1-8.
PDF: https://canadiangeriatrics.ca/wp-content/uploads/2021/02/GDH-Environmental-Scan-Report_Formatted.pdf 

Author(s): Farrell B, Clarkin C, Conklin J, Dolovich L, Irving H, McCarthy L, Raman-Wilms L. (2020).
Title: Community pharmacists as catalysts for Deprescribing: an exploratory study using quality improvement processes.
Journal: Canadian Pharmacists Journal, 153(1), 37-45.
Doi: 10.1177/1715163519882969

Author(s): Farrell B, Grad R, Howell P, Quast T, Reeve E. (2020).
Title: Deprescribing Guidelines: Value of an Interactive Mobile Application.
Journal: PRiMER, 4(26), 1-10.
Doi: 10.22454/PRiMER.2020.349237

Author(s): Farrell B, Jeffs L, Irving H, McCarthy LM. (2020).
Title: Patient and provider perspectives on the development and resolution of prescribing cascades: a qualitative study.
Journal: BMC Geriatrics, 20(368), 1-11.
Doi: 10.1186/s12877-020-01774

Author(s): Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, Conklin J, Dolovich L, McCarthy L, Farrell B. (2019).
Title: Deprescribing: future directions for research.
Journal: Research in Social and Administrative Pharmacy, 15(6), 801-805.
Doi: https://www.sciencedirect.com/science/article/pii/S1551741118307757

Author(s): Dolovich L, Waite N, Austin Z, Houle S, McCarthy L, MacCallum L, Grindrod K, Chang F, Farrell B, Sproule B. (2019).
Title: Pharmacy in the 21st century: enhancing the impact of the profession of pharmacy on people’s lives in the context of healthcare trends, evidence and policies.
Journal: Canadian Pharmacists Journal, 152(1), 45-53.
Doi: https://journals.sagepub.com/doi/10.1177/1715163518815717

Author(s): Farrell B, Archibald D, Pizzola L, Ward N, Cho A, Tsang C. (2019).
Title: Impact on confidence and practice: how the ADAPT online patient care skills program made a difference for pharmacists.
Journal: Research in Social and Administrative Policy, 15(10), 1251-1258.
Doi: 10.1016/j.sapharm.2018.11.001

Author(s): Lee JY, Farrell B, Holbrook AM. (2019).
Title: Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines.
Journal: Polish Archives of Internal Medicine, 129(1), 43-49.
Doi: http://dx.doi.org/10.20452/pamw.4391

Author(s): Greiver M, Dahrouge S, O’Brien P, Manca D, Lussier MT, Wang J, Burge F, Grandy M, Singer A, Twohig M, Moineddin R, Kalia S, Aliarzadeh B, Ivers N, Garies S, Turner JP, Farrell B. (2019).
Title: Improving care for elderly patients living with polypharmacy: protocol for a pragmatic cluster randomized trial in community based primary care practices in Canada.
Journal: Implementation Science, 14(55), 1-15.
Doi: 10.1186/s13012-019-0904-4

Author(s): Conklin J, Farrell B, Suleman S. (2019).
Title: Implementing deprescribing guidelines into frontline practice: Barriers and facilitators.
Journal: Research in Social and Administrative Pharmacy, 15(6), 796-800.
Doi: https://www.sciencedirect.com/science/article/abs/pii/S1551741118307526?via%3Dihub

Author(s): Raman-Wilms L, Farrell B, Sadowski C, Austin Z. (2019).
Title: Deprescribing: an educational imperative.
Journal: Research in Social and Administrative Pharmacy, 15(6), 790-795.
Doi: https://www.sciencedirect.com/science/article/pii/S1551741118307745 

Author(s): Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W. (2019).
Title: Deprescribing guidelines: an international symposium on development, implementation, research and health professional education.
Journal: Research in Social and Administrative Pharmacy, 15(6), 780-789.
Doi: https://www.sciencedirect.com/science/article/pii/S1551741118307447

Author(s): Thompson W, Farrell B, Welch V, Tugwell P, Way C, Richardson L, Bjerre L. (2019).
Title: Continuation or deprescribing of proton pump inhibitors: A consult patient decision aid.
Journal: Canadian Pharmacists Journal, 152(1), 18-22.
Doi: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346337

Author(s): Moriarty F, Pottie K, Dolovich L, McCarthy L, Rojas-Fernandez C, Farrell B**. (2019).
Title: Deprescribing recommendations: an essential consideration for clinical guideline developers.
Journal: Research in Social and Administrative Pharmacy, 15(6), 806-810.
Doi: https://www.sciencedirect.com/science/article/pii/S1551741118307770

Author(s): Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin P, Chenoweth L, Gorman M, Quirke L, Bethune G, Forbes F, Hilmer S. (2018).
Title: Evidence-based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine.
Journal: University of Sydney.
Doi: http://sydney.edu.au/medicine/cdpc/resources/deprescribing-guidelines.php

Author(s): Farrell B, Thompson W, Black C, Archibald D, Raman-Wilms L, Grassau P, Patel T, Weaver L, Eid K, Winslade N. (2018).
Title: Healthcare providers’ roles and responsibilities in management of polypharmacy: Results of a modified Delphi.
Journal: Canadian Pharmacists Journal, 151(6), 395-407.
Doi: https://doi.org/10.1177%2F1715163518804276

Author(s): Farrell B, Thompson W, Black C, Archibald D, Raman-Wilms L, Grassau P, Patel T, Weaver L, Eid K, Winslade N. (2018).
Title: Operationalizing the Canadian Interprofessional Health Collaborative (CIHC) Competency Framework for team management of polypharmacy in older persons: a modified Delphi validation.
Journal: Canadian Pharmacists Journal, 151(6), 395-407.
Doi: https://journals.sagepub.com/doi/10.1177/1715163518804276

Author(s): Turner JP, Richard C, Lussier MT, Lavoie ME, Farrell B, Roberge D, Tannenbaum C. (2018).
Title: Deprescribing conversations: a closer look at prescriber-patient communication.
Journal: Therapeutic Advances in Drug Safety, 9(12), 687-698.
Doi: https://doi.org/10.1177%2F2042098618804490

Author(s): Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B. (2018).
Title: Deprescribing benzodiazepine receptor agonists: Evidence based clinical practice Guideline.
Journal: Canadian Family Physician, 64(5), 339-351.
Link: https://www.cfp.ca/content/64/5/339 

Author(s): Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas-Fernandez C, Sinha S, Thompson W, Welch V, Wiens A. (2018).
Title: Deprescribing antipsychotics for behavioural and psychological symptoms of dementia (BPSD) and insomnia: Evidence-based clinical practice guideline.
Journal: Canadian Family Physician, 64(1), 17-27.
PDF: https://www.cfp.ca/content/cfp/64/1/17.full.pdf

Author(s): Tannenbaum C, Farrell B, Shaw J, Morgan S, Trimble J, Currie J, Turner J, Rochon P, Silvius J. (2017).
Title: An ecological approach to reduce the use of potentially inappropriate medications in Canada: the Canadian Deprescribing Network.
Journal: Canadian Journal on Aging, 36(1), 97-107.
Doi: 10.1017/S0714980816000702

Author(s): Reeve E, Thompson W, Farrell B. (2017).
Title: Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
Journal: European Journal of Internal Medicine, 38, 3-11.
Doi: 10.1016/j.ejim.2016.12.021